Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children Antiviral Therapy.
2011.
16
(8):
1287-1295.
Pharmacokinetics of Nevirapine in Human Immune Deficiency Virus and Tuberculosis Co-infected Children Receiving Antiretroviral Fixed-Dose Combination Tablets While Receiving Rifampicin-Containing Tuberculosis Treatment and after Rifampicin Discontinuation Pediatric Infectious Disease Journal.
2011.
A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa JOURNAL OF THE INTERNATIONAL AIDS SOCIETY.
2011.
14
Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants International Journal of Infectious Diseases.
2011.
15
(4):
e249-e256.
Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand Journal of Paediatrics and Child Health.
2011.
47
(1-2):
27-33.
Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report Pediatric Pulmonology.
2011.
46
(1):
60-66.
Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population PLoS ONE.
2011.
6
(1):